contains the active ingredient meloxicam
Consumer Medicine Information
This leaflet answers some common questions about MOVALIS.
It does not contain all of the available information. It does not take the place of talking to your doctor or pharmacist.
All medicines have benefits and risks. Your doctor has weighed the risks of you taking MOVALIS against the benefits they expect it will have for you.
If you have any concerns about taking this medicine, talk to your doctor or pharmacist.
Keep this leaflet with your medicine. You may need to read it again.
MOVALIS is used to treat the symptoms of osteoarthritis, a painful joint disease most commonly affecting the hips, knees, and spine. Although MOVALIS can relieve symptoms such as pain and inflammation, it will not cure your condition.
MOVALIS belongs to a family of medicines called Non-Steroidal Anti-inflammatory Drugs (NSAIDs). These medicines work by relieving pain and inflammation.
MOVALIS is available only with a doctor's prescription.
Do not take MOVALIS if you are allergic to:
Some of the symptoms of an allergic reaction may include skin rash, itching or hives, swelling of the face, lips, tongue or other parts of the body, shortness of breath, wheezing or troubled breathing.
Do not take MOVALIS if:
Do not take MOVALIS if you are breastfeeding.
MOVALIS may pass into breast milk and may affect your baby.
Do not take MOVALIS if the expiry date (Exp.) printed on the pack has passed.
Do not take MOVALIS if the packaging shows signs of tampering or the tablets or capsules do not look quite right.
Do not give MOVALIS to children or adolescents under 18 years of age.
Tell your doctor if you have allergies to:
Tell your doctor if you are pregnant or plan to become pregnant.
Like most NSAIDs, MOVALIS is not recommended for use during the last 3 months of pregnancy. It may affect your developing baby if you take it while you are pregnant
Tell your doctor if you have, any medical conditions, especially the following:
Tell your doctor if you are taking any medicines used to treat high blood pressure and some other heart problems such as ACE inhibitors, angiotensin receptor antagonists and diuretics (also called fluid or water tablets).
Taking MOVALIS together with these medicines can cause kidney problems.
Tell your doctor if you are using an IUD for birth control.
If you have not told your doctor about any of the above, tell them before you start taking MOVALIS.
Tell your doctor if you are taking any other medicines, including any that you buy without a prescription from a pharmacy, supermarket or health food shop.
Some medicines may be affected by MOVALIS, or may affect how well it works. These include:
Your doctor can tell you what to do if you are taking any of these medicines.
If you are not sure whether you are taking any of these medicines, check with your doctor or pharmacist.
Your doctor and pharmacist have more information on medicines to be careful with or avoid while taking MOVALIS.
The usual dose of MOVALIS is 7.5 mg, taken as a single dose each day.
However, your doctor will prescribe a dose suitable for your condition.
The maximum recommended daily dose of MOVALIS is 15 mg.
For patients with kidney problems undergoing dialysis, the maximum recommended daily dose is 7.5 mg.
Follow all directions given to you by your doctor and pharmacist carefully.
Swallow the tablets or capsules with a glass of fluid.
It is best to take MOVALIS immediately after food to avoid the chance of an upset stomach.
Try to take MOVALIS at the same time each day, either morning or evening.
If it is almost time for your next dose, skip the dose you missed and take your next dose when you are meant to.
Otherwise, take the missed dose as soon as you remember, and then go back to taking your tablets as you would normally.
Do not take a double dose to make up for the dose you missed.
If you are not sure what to do, ask your doctor or pharmacist.
Keep taking MOVALIS every day for as long as your doctor recommends.
You may need to take MOVALIS for a long time. It will not cure your condition, but it should help control pain, stiffness and swelling.
Immediately telephone your doctor, or the Poisons Information Centre (telephone 13 11 26), or go to Accident and Emergency at the nearest hospital, if you think you or anyone else may have taken too much MOVALIS. Do this even if there are no signs of discomfort or poisoning.
You may need urgent medical attention.
Signs of an overdose with MOVALIS may include:
Before starting any new medicine, tell your doctor or pharmacist that you are taking MOVALIS.
Tell all the doctors, dentists and pharmacists who are treating you that you are taking MOVALIS.
If you become pregnant while taking MOVALIS, tell your doctor immediately.
If you plan to have surgery, including dental surgery, tell your doctor or dentist that you are taking MOVALIS.
MOVALIS can slow down blood clotting.
If you get an infection while using MOVALIS, tell your doctor.
MOVALIS may hide some of the signs of an infection (eg. pain, fever, redness and swelling). You may think, mistakenly, that you are better or that the infection is not serious.
Do not use MOVALIS to treat any other conditions unless your doctor tells you to.
Do not give MOVALIS to anyone else, even if they have the same condition as you.
Be careful driving or operating machinery until you know how MOVALIS affects you.
As with other NSAID medicines, MOVALIS may cause dizziness, drowsiness or blurred vision in some people.
Make sure you know how you react to MOVALIS before you drive a car, operate machinery, or do anything else that could be dangerous if you are not alert.
Tell your doctor or pharmacist as soon as possible if you do not feel well while you are taking MOVALIS.
Like all other medicines, MOVALIS may have unwanted side effects in some people. Sometimes they are serious, most of the time they are not. You may need medical treatment if you get some of the side effects.
Do not be alarmed by this list of possible side effects.
You may not experience any of them.
Ask your doctor or pharmacist to answer any questions you may have.
Tell your doctor if you notice any of the following and they worry you:
These side effects are usually mild.
Tell your doctor immediately if you notice any of the following:
These are rare but serious side effects. You may need urgent medical attention.
If any of the following happen, stop taking MOVALIS and tell your doctor immediately, or go to Accident and Emergency at the nearest hospital:
These are rare but very serious side effects. You may need urgent medical attention or hospitalisation.
Not all of these side effects have been reported with MOVALIS but have been seen with similar medicines.
Other side effects not listed above may also occur in some patients. Tell your doctor if you notice anything that is making you feel unwell.
Keep MOVALIS where children cannot reach it. A locked cupboard at least one-and-a-half metres above the ground is a good place to store medicines.
Keep your tablets or capsules in the pack until it is time to take them. If you take them out of their packaging they may not keep well.
Keep your tablets or capsules in a cool dry place where the temperature stays below 25°C.
Do not store MOVALIS or any other medicine in the bathroom or near a sink.
Do not leave MOVALIS in the car or on window sills.
Heat and dampness can destroy some medicines.
If your doctor tells you to stop taking MOVALIS, or your tablets or capsules have passed their expiry date, ask your pharmacist what to do with any that are left over.
MOVALIS tablets come in 2 strengths:
MOVALIS capsules come in 2 strengths:
Each pack contains 30 tablets or capsules.
The active ingredient in MOVALIS is meloxicam:
The tablets also contain:
The capsules also contain:
The tablets and capsules are gluten free .
MOVALIS is supplied by:
Sigma Pharmaceuticals (Australia) Pty Ltd
96 Merrindale Drive
Croydon Vic 3136
Tel: 03 - 9839 2800
Australian registration numbers:
MOVALIS 7.5 mg tablet
- AUST R 99152
MOVALIS 15 mg tablet
- AUST R 99154
MOVALIS 7.5 mg capsule
- AUST R 142228
MOVALIS 15 mg capsule
- AUST R 142229
Date of preparation:
Published by MIMS May 2010